GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 72 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $205 | +40.4% | 106,522 | +4.9% | 0.00% | – |
| Q2 2023 | $146 | -31.5% | 101,522 | 0.0% | 0.00% | – |
| Q1 2023 | $213 | +86.8% | 101,522 | 0.0% | 0.00% | – |
| Q4 2022 | $114 | -99.8% | 101,522 | +165.6% | 0.00% | – |
| Q3 2022 | $62,000 | +24.0% | 38,220 | 0.0% | 0.00% | – |
| Q2 2022 | $50,000 | +16.3% | 38,220 | +42.1% | 0.00% | – |
| Q1 2022 | $43,000 | +26.5% | 26,902 | +59.2% | 0.00% | – |
| Q4 2021 | $34,000 | -26.1% | 16,902 | +42.0% | 0.00% | – |
| Q3 2021 | $46,000 | -23.3% | 11,902 | -27.2% | 0.00% | – |
| Q3 2019 | $60,000 | -4.8% | 16,352 | +7.2% | 0.00% | – |
| Q2 2019 | $63,000 | +1.6% | 15,247 | +25.1% | 0.00% | – |
| Q1 2019 | $62,000 | +63.2% | 12,188 | +8.9% | 0.00% | – |
| Q4 2018 | $38,000 | – | 11,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 184,742 | $401,000 | 0.10% |
| Geneos Wealth Management Inc. | 511,606 | $2,261,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $26,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 18,967 | $41,000 | 0.01% |
| Vivaldi Capital Management LP | 10,668 | $45,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,221,984 | $2,651,000 | 0.01% |
| CENTAURUS FINANCIAL, INC. | 15,614 | $34,000 | 0.00% |
| WEDBUSH SECURITIES INC | 17,998 | $39,000 | 0.00% |
| D.A. DAVIDSON & CO. | 65,310 | $142,000 | 0.00% |
| Virtu Financial LLC | 14,683 | $32,000 | 0.00% |